Navigation Links
Global Patient Safety Highlighted by NABP, Domestic and International Stakeholders at .Pharmacy Supporter Advisory Committee Meeting
Date:8/5/2014

MOUNT PROSPECT, Ill., Aug. 5, 2014 /PRNewswire-USNewswire/ -- The National Association of Boards of Pharmacy® (NABP®) welcomed domestic and international stakeholders last week for a meeting of the .Pharmacy Supporter Advisory Committee. The committee's guidance is an important part of operationalizing the new .pharmacy generic Top-Level Domain (gTLD). Members of the committee, which is composed of representatives of domestic and international regulatory agencies and patient safety advocacy groups, as well as technical and industry experts, stressed the importance of implementing standards and policies to support the .pharmacy program's goal to provide patients and consumers around the world a means for identifying safe, legal, and ethical online pharmacies and related resources.

The advisory committee discussed implementation of the .pharmacy standards, including issues related to the international operationalization of the gTLD. International stakeholders, in particular European Alliance for Access to Safe Medicines, International Pharmaceutical Federation, National Association of Pharmacy Regulatory Authorities, and Ordre National des Pharmaciens, shared their expertise on regulatory and pharmacy practice matters. NABP will continue to collaborate with advisory committee members, particularly its international members, to ensure that global implementation of the .pharmacy gTLD meets the unique laws and concerns of each jurisdiction in which the domain is used. The advisory committee meeting followed NABP's execution of a Registry Agreement with the Internet Corporation for Assigned Names and Numbers on June 19, 2014, to become the registry operator for the new .pharmacy gTLD.

NABP plans to launch the .pharmacy gTLD by fall 2014, and, working closely with the .Pharmacy Supporter Advisory Committee, will implement policies to ensure that only legitimate website operators that adhere to pharmacy laws in the jurisdictions in which they are based and to which they sell medicine will be able to register domain names in .pharmacy. For example, a pharmacy that is licensed in another country and is selling prescription drugs to patients in the United States would not be eligible for .pharmacy because it is violating US federal law that prohibits importation. Similarly, Internet pharmacies dispensing prescription medications to patients in France would not be eligible for the .pharmacy domain because French law prohibits the online sale of prescription drugs. The .pharmacy eligibility requirements were developed to address concerns shared by domestic and international stakeholders about illegal online drug sellers distributing products that endanger patient health worldwide.

NABP continues to monitor websites selling prescription drugs to patients in the US and, as of July 2014, has reviewed over 10,780 Internet drug outlets and found 97% of them to be out of compliance with pharmacy laws and practice standards established in the US to protect the public health. Of the 10,434 websites identified as Not Recommended, nearly half offer foreign or non-Food and Drug Administration (FDA)-approved drugs, many of which may be dangerous counterfeits, to unsuspecting US patients. Further, health and regulatory agencies in the US and abroad have reported cases of patients harmed by counterfeit, substandard, and adulterated medications distributed by illegal Internet sellers.

Among the global coalition of stakeholders behind the .pharmacy initiative are the Alliance for Safe Online Pharmacies, Eli Lilly and Company, European Alliance for Access to Safe Medicines, FDA, Gilead Sciences, Inc, International Pharmaceutical Federation, INTERPOL, Janssen Pharmaceuticals, Inc, LegitScript, Merck & Co, Inc, National Association of Pharmacy Regulatory Authorities, Pfizer, and state boards of pharmacy.

More information about NABP and the .Pharmacy gTLD Program, including program updates and a request-for-information form for entities seeking a .pharmacy gTLD, is available at www.dotpharmacy.net.

NABP is the independent, international, and impartial Association that assists its state member boards and jurisdictions for the purpose of protecting the public health.


'/>"/>
SOURCE National Association of Boards of Pharmacy
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
8. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... YORK , Jan. 17, 2017 The ... 8.02 billion by 2021 from USD 6.35 billion in ... factors driving the growth of this market are rising ... demand for minimally invasive surgeries. The global ... procedure, application, and region. On the basis of type, ...
(Date:1/17/2017)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced ... Phase 3 clinical trial comparing the efficacy and safety ... prevention of hepatic veno-occlusive disease (VOD) in adult and ... are at high risk or at very high risk ... conducted across approximately 100 medical centers in ...
(Date:1/17/2017)... -- Market Research Future published a Half Cooked Research Report on Endoscopy ... USD 33.6 million during the period 2016 to 2022 from USD ... ... been examined as a swiftly growing market and expected to grow ... device in various regions.  The increasing growth in endoscopy procedures is ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... Floundering on New Year’s ... and the perfect time for a reset. The U.S. Apple Association agrees and recommends ... many of the factors that contribute to heart disease. , The U.S. Apple Association ...
(Date:1/17/2017)... ... , ... For breast cancer clinicians and researchers who were unable to attend ... intimate review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th Annual ... on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, FASCO ...
(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic Research will demonstrate its ... Merchants (NAMM) winter trade show, Booth #2876, at the Anaheim Convention Center in ... the gold standard for high-definition, in-ear earphones. This classic earphone has been updated ...
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples ... the Peoples Health network on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare ... Center is an exciting addition to our provider network, and the addition will ...
(Date:1/17/2017)... ... 17, 2017 , ... Wettstein Agencies, a Denver area firm ... throughout central Colorado, is joining local nonprofit Aurora Warms The Night to provide ... organization is committed to breaking the cycle of homelessness and poverty affecting a ...
Breaking Medicine News(10 mins):